INTRODUCTION
Articular cartilage is predominantly composed of an insoluble fibrous collagen network immersed in a highly hydrated gel of high-Mr proteoglycan aggregate (for review, see Muir, 1980; Handley et al., 1985) . It is the presence of the proteoglycan molecule within the extracellular matrix that gives articular cartilage its unique ability to withstand compressive forces. Since the rate of turnover of proteoglycans within the extracellular matrix is relatively fast (Campbell et al., 1984) compared with the collagen, the regulation of proteoglycan metabolism is therefore paramount to the correct physiological function of articular cartilage.
A variety of hormones and growth factors have been cited as stimulators of cartilage growth and chondrocyte multiplication, and the efficiency of each process appears to be dependent on both the culture system used and the assay conditions employed. The identification of circulating growth factors with the potential to modulate proteolgycan metabolism by articular cartilage is important to the understanding of the regulation of growth and maintenance of this tissue. Furthermore, these factors may play a role in the repair of articular cartilage after damage.
We have developed and characterized a culture system for bovine articular cartilage explants (Hascall et al., 1983; McQuillan et al., 1986b) in which the phenotype is maintained in both the presence and absence of serum. The ability to modulate the rate of proteoglycan synthesis makes this system ideal for the study of mechanisms controlling proteoglycan synthesis (McQuilIan et al., 1984 (McQuilIan et al., , 1986a . We have now exploited this explant culture system to show that it is the insulin-like growth factors (IGFs) present in foetal calf serum that are responsible for the stimulation of proteoglycan synthesis. Furthermore, we have shown that substitution of foetal calf serum by recombinant IGF-I in the culture medium permits the type, rate of synthesis and tissue levels of proteoglycans in adult articular cartilage to be maintained for up to 5 days. prepared as described previously (Hascall et al., 1983) . Minced cartilage tissue was maintained in culture for up to 10 days in a modification of Dulbecco's modified Eagle's medium (Handley & Lowther, 1977) or the same medium supplemented with either foetal calf serum, serum fractions or hormones as indicated under 'Results'. Tissue was distributed into individual portions of 50-100 mg wet wt. for all experiments.
Labelling of proteoglyeans with 135Slsulphate
Cartilage cultures were preincubated in fresh medium for 1 h prior to incubation in the presence of 2 ml of medium containing 20-30,Ci of [35S]sulphate/ml. Incubations were performed at 37°C in a shaker bath in loosely capped culture vials for 1-2 h.
Extraction procedures
Cartilage cultures which had been incubated with [35S]sulphate were extracted at 4°C for 2-4 days with 2 ml of4 M-guanidiniumchloride/0.05 M-sodium acetate/ acetic acid, pH 5.8, in the presence of proteinase inhibitors (1 mM-benzamidine hydrochloride, 100 mm-6-aminohexanoic acid, 10 mM-N-ethylmaleimide, 1 mmphenylmethanesulphonyl fluoride, 10 mM-EDTA); more than 70% of35S-labelled proteoglycans were extracted by this treatment (Hascall & Kimura, 1982) . The remaining 35S-labelled macromolecules were extracted with 2 ml of 0.5 M-NaOH. In addition, cartilage explants were extracted directly with 2 ml of 0.5 M-NaOH to solubilize the total glycosaminoglycan pool in one step. The rate of [35S]sulphate incorporation into macromolecules was determined by elution on Sephadex G-25 (PD-10) columns (Hascall et al., 1983) .
Analytical gel chromatography 35S-labelled proteoglycans and glycosaminoglycans were analysed on columns of Sepharose CL-2B and CL-6B (0.8 cm x 100 cm) eluted with 4 M-guanidinium chloride/0.2 M-Na2SO4/0.5% (v/v) Triton X-I 00/0. 1 Msodium acetate/acetic acid, pH 6.0, at a flow rate of 6 ml/h. Fractions (1.4 ml) were collected and assayed for radioactivity.
Preparative gel chromatography of serum Under neutral pH conditions. Foetal calf serum was dialysed extensively against phosphate-buffered saline (0.4 M-NaCl, 3 mM-KCl, 3 mM-Na2HPO4, 1 mM-KH2PO4, pH 7.4) at 4 'C. The dialysis residue was centrifuged at 60000 g for 30 min to remove any precipitate. Portions (5-10 ml) of the residue were eluted in a column (2.5 cm x 80 cm) of Sephadex G-75 equilibrated in phosphate-buffered saline. Fractions (-_40 ml) were collected and assayed for protein content (Bradford, 1976) . Every two fractions were pooled, dialysed against water, lyophilized, resuspended in a small amount of 1 M-acetic acid and made up to an appropriate volume with culture medium. Each fraction was then adjusted to pH 7.4 with concentrated NaOH and sterilized by passage through a 0.45,m membrane.
Under acid pH conditions. Foetal calf serum was dialysed extensively against 1 % (v/v) formic acid, pH 2.4 at 4°C. The dialysis residue was treated in the same manner as described above for neutral pH chromatography except that the column of Sephadex G-75 was equilibrated and eluted with 1 % (v/v) formic acid, pH 2.4.
Gel chromatography on Sephadex G-50. Fractions of foetal calf serum eluting on Sephadex G-75 under acid conditions between Kav 0.25 and 0.75 were pooled and concentrated by ultrafiltration using an Amicon membrane with an exclusion limit of 500 Da. A portion of the retentate was applied to a Sephadex G-50 column (1.8 cm x 90 cm) equilibrated with 1 % (v/v) formic acid and pre-calibrated with standard proteins. Eluted fractions (-4.5 ml) were assayed for protein content and the ability to stimulate proteoglycan synthesis in cultures of bovine articular cartilage.
Isoelectric focusing
Preparative flat-bed electrofocusing, over the pH range 3.5-10.0, was performed in a gel of Sephadex G-75 as described by Radola (1975) . The sample to be applied was first dialysed against phosphate-buffered saline, pH 7.4, at 4 'C. The sample was applied to the centre of the gel bed and electrofocusing was performed at 10 'C for 16 h. The gel bed was divided into 30 equal fractions and the gel in each fraction was eluted with a portion of the running buffer. The pH and protein content of each eluate was determined and pooled as described under 'Results'. Samples were dialysed against phosphatebuffered saline to remove ampholytes, and then assayed for stimulatory activity in the bovine articular cartilage culture system. Measurement of proteoglycan turnover Articular cartilage from a single steer was maintained in medium containing 20% (v/v) foetal calf serum for 6 days and then incubated for 6 h with 300 #Ci of [35S]sulphate in 10 ml of medium containing 20% (v/v) foetal calf serum (Campbell et al., 1984) . The tissue was then washed three times in medium alone prior to distribution into individual vials (-100 mg oftissue/vial) containing medium appropriate to each experiment. The medium from each culture was collected every 24 h and replaced with 4 ml of fresh medium. After 5 days in culture the tissue was extracted with 4 M-guanidinium chloride for 2 days, followed by 0.5 M-NaOH for 24 h at room temperature. The culture medium, guanidinium chloride and NaOH extracts were analysed for 35S-labelled proteoglycans by chromatography on Sephadex G-25 (PD-10) columns, and from these data the percentage of 35S-labelled proteoglycans remaining in the matrix was determined (Campbell et al., 1984) .
RESULTS
Temperature-and pH-stability of serum activity Preliminary experiments were carried out to investigate the heat and pH-stability of the activity in serum responsible for the stimulation of proteoglycan synthesis by articular cartilage explants. Samples from the same batch of serum were incubated under sterile conditions for 5-30 min at temperatures of 50-100 'C or at pH 1, 2, 3 at 4 'C overnight. The samples were either clarified by centrifugation at 50000 g for 30 min or neutralized before being reconstituted with culture medium at a final concentration of 20% (v/v To test whether the proteoglycan-stimulatory activity present in foetal calf serum exists in acid-dissociable complexes, portions of foetal calf serum, previously dialysed against the appropriate solvent, where subjected to gel filtration on Sephadex G-75 equilibrated in phosphate-buffered saline, pH 7.4 (neutral conditions) or 10% (v/v) formic acid (acid conditions), as described previously (Franklin et al., 1979) . Samples of the neutral and acid-treated serum were taken prior to gel filtration and showed no loss of proteoglycan stimulatory activity Fig. 2 . Sephadex G-50 chromatography of the active fractions obtained from foetal calf serum A sample of foetal calf serum (20 ml) was dialysed against 1 % (v/v) formic acid and 5 ml portions were applied to Sephadex G-75 eluted under acid conditions. Equivalent fractions eluting from each column between Kay 0.25 and 0.75 were pooled, dialysed against phosphate-buffered saline, pH 7.4, and concentrated to 4 ml by ultrafiltration. A sample (2 ml; 5.1 mg of protein/ml) was applied to a column of Sephadex G-50 equilibrated with 10% (v/v) formic acid. Every two fractions were pooled and dialysed against phosphate-buffered saline, pH 7.4, prior to sterilization. The fractions were added to culture medium at a concentration of 19% (v/v) and the proteoglycanstimulatory activity was assessed (bars) as described in the legend to Fig. 1 Fractions were assayed for protein content and pooled as indicated (1-7). Pooled fractions were dialysed against phosphate-buffered saline, pH 7.4, prior to addition to culture medium at a concentration of 16% (v/v) . Activity (bars) of each fraction was determined as described in the legend to Fig. 1 . Each fraction was assayed in triplicate; the S.D. was less than +6% in all cases. compared with untreated foetal calf serum (results not shown).
Gel filtration of foetal calf serum under neutral conditions revealed a peak of activity near the void volume of the column (Fig. 1, upper panel) . Filtration of the same batch of foetal calf serum in 1 % (v/v) formic acid showed a marked shift in the peak of activity to a lower-Mr region of the column (Fig. 1, lower panel) . Under acid conditions, the peak of activity eluted at a Kav of about 0.76. Although the bulk of activity had shifted to a low-Mr position under acid conditions, a small peak of activity remained near the void volume. This activity may represent undissociated carrier protein-IGF complexes or a high-Mr component known to possess non-suppressible insulin-like activity (Poffenbarger, 1975; Franklin et al., 1979) which has not been previously reported to exhibit proteoglycan-stimulatory activity in cartilage. In other experiments, this acid-stable high-Mr activity was not always apparent and never constituted more than 10% of the total activity recovered.
Hydrodynamic size of the active serum factors A portion (2 ml; -5.1 mg of protein/ml) of the pooled fractons eluting from Sephadex G-75 under acid conditions with Kav 0.25-0.75 was re-chromatographed on a Sephadex G-50 column in 1 % (v/v) formic acid, pH 2.4. The elution profile obtained (Fig. 2) shows an included region of activity between Kav 0.20 and 0.53 with the peak of activity eluting at Kay 0.37 (Mr-10000), consistent with the Mr of free IGFs (-7500).
Isoelectric point of serum factors
Evidence that the proteoglycan-stimulatory activity in foetal calf serum was largely attributable to IGFs was provided by determination of the pl of the active fraction from serum. A portion (2 ml) of the active fraction from Sephadex G-75 chromatography eluted under acid conditions was subjected to isoelectric focusing across the pH range 3.5-10.0 (Fig. 3) . Each pooled fraction was dialysed to remove ampholytes, and then assayed for activity. The profile (Fig. 3) shows three active fractions, two ofwhich are adjacent, corresponding to isoelectric points of 4.3-5.5, 6.5-7.0, and 7.3-8.3. These pH ranges correlate well with isoelectric points for IGFs in human serum (Van Wyk et al., 1980; Kuffer & Herington, 1984) . Effects of foetal calf senum treated with monoclonal antibody to IGF-1 on proteoglycan synthesis by articular cartilage Articular cartilage was maintained in culture for 5 days in medium alone and then incubated for a further 3 days in medium alone, medium containing the monoclonal antibody (SM 1.20B) against IGF-1, medium containing 10% (v/v) foetal calf serum, or medium containing 10% foetal calf serum and the same monoclonal antibody to IGF-1. The monoclonal antibody was added to culture medium to give a final dilution of antibody of 1:480 (32 jug/ml). The tissue was then proteoglycan synthesis by tissue maintained in the presence of serum ([l) whereas tissue exposed to 20 ng of IGF-1 /ml (0) exhibited a 1.5-fold increase in the rate of synthesis by day 3 compared with the day 0 control. This elevated rate of synthesis was maintained up to day 5 of culture. Tissue cultured throughout with 0.01 % (w/v) albumin (A) showed a steady decline in the rate of synthesis to reach 45% of the day 0 control value by day 5. Cultures maintained either in the presence of foetal calf serum (EO) or IGF-I (0) for 5 days showed no change in the amount of proteoglycan in the tissue, suggesting that an equilibrium between proteoglycan synthesis and degradation was achieved. Cultures maintained in the absence of serum (A) showed a significant decrease in uronic acid content to 76% of day 0 control cultures, indicating that the rate ofproteoglycan catabolism exceeded the rate of proteoglycan anabolism.
In a separate experiment, cultures were maintained in the presence of medium alone for 5 days and were then exposed for up to 5 days either with 20% foetal calf serum (Fig. 6 , El) or 20 ng of IGF-I/ml (Fig. 6, 0) . On days 7 and 10 the rate of proteoglycan synthesis was determined; compared with day 5 control cultures, the rate of proteoglycan synthesis on day 10 was stimulated 2.7-and 2.0-fold by serum and IGF-I respectively. In the absence of serum, the rate of proteoglycan synthesis decreased to 53% of the day 5 control cultures. The stimulation in the rate of proteoglycan synthesis induced by IGF-I was 70% of that induced by 20% foetal calf serum. For tissue cultured in the presence ofhydroxyurea, an inhibitor of DNA synthesis, IGF-I stimulated the rate of proteoglycan synthesis to 80% of that observed in cultures maintained in medium containing serum and hydroxyurea, confirming our previous observation (McQuillan et al., 1986b ) that DNA synthesis was not a necessary prerequisite for a stimulation of proteoglycan synthesis to occur (results not shown).
The hydrodynamic size of the proteoglycans synthesized by the explant cultures in the presence of IGF-I was investigated. The elution profile of the day 0 control (Fig.  7a) shows the presence of two distinct species characteristic of this tissue (Hascall et al., 1983) hormone (NIH-GH-B-1 8) was tested for its effect on the rate of proteoglycan synthesis by adult bovine articular cartilage in vitro. No stimulation was apparent at any of the concentrations tested (10-1000 ng/ml) covering the high physiological to relatively high pharmacological range (Table 1) .
Insulin significantly stimulated proteoglycan synthesis by cartilage only at pharmacological concentrations, with a maximal response of 3300 above control levels observed at a concentration of 10 ,ug of insulin/ml. In other experiments employing a similar protocol, fibroblast growth factor, epidermal growth factor, and relaxin were tested, but no stimulation in proteoglycan synthesis was observed (results not shown).
Effect of recombinant IGF-I on proteoglycan catabolism
Maintenance of tissue proteoglycan levels comparable with those measured in freshly dissected articular cartilage was obtained by incubating cartilage cultures in the presence of IGF-I (Fig. 5, lower panel) . To ascertain whether this was entirely attributable to maintenance of elevated rates of proteoglycan synthesis or to changes in the rate of proteoglycan catabolism, the effect of recombinant IGF-I on proteoglycan catabolism by cartilage explants was investigated. On the basis of the 35S-labelled proteoglycans appearing in the respective media on each day (Fig. 8) (0) indicating that cells actively synthesizing proteins were required for proteoglycan catabolism to occur. These data suggest that it is an IGF-mediated maintenance of a high rate of proteoglycan synthesis that determines the levels of proteoglycan in the tissue. In a similar experiment, bovine growth hormone (100 ng/ml of medium) was also shown to have no effect on the rate of loss of labelled proteoglycan from the matrix of the cultures (ti 9.0 days) compared with control tissue (ti 8.7 days).
DISCUSSION
It has been shown that the factor(s) present in foetal calf serum, and responsible for the maintenance of proteoglycan synthesis by articular cartilage, were relatively heat-and acid-stable and were of Mr < 10000, although in serum were bound in a biologically active, acid-dissociable, high-Mr complex. These observations strongly suggest that the factors belong to the IGF family (Smith, 1984) . Furthermore, the proteoglycan-stimulatory activity could be resolved by isoelectric focusing into at least two distinct components with pIs comparable with those of the IGF/somatomedin family. The probable identity of these factors with the IGFs (IGF-I in particular) was further indicated by their inactivation by an anti-IGF-I monoclonal antibody and the reproVol. 240 duction of their actions by the addition of physiological concentrations of highly purified human IGF-I. It has recently been shown (Honegger & Humbel, 1986 ) that bovine and human IGF-I are identical.
These data are consistent with the postulate that IGFs may be crucial for the homeostasis of the extracellular matrix of articular cartilage in vivo. Indeed, it has been reported by a number of workers that chondrocytes of bovine cartilage possess receptors for IGF-I (Trippel et al., 1983; Watanabe et al., 1985) . Furthermore, the ability of high pharmacological concentrations of insulin to stimulate proteoglycan synthesis supports the role of IGFs in the regulation of the metabolism of articular cartilage. Hajek & Solursh (1975) reported a similar response to insulin for glycosaminoglycan synthesis by chick embryo chondrocytes. The substantial sequence homology between IGF-I and insulin (Humbel & Rinderknecht, 1979) and the ability of high concentrations () 1 ug/ml) of insulin to cross-react with IGF-I receptors in many tissues (Froesch, 1983) , may account for these observations. Growth hormone had no direct effect on the synthesis of proteoglycans by adult bovine articular cartilage in this culture system. This finding is in agreement with most observations that the action of this hormone on articular cartilage is mediated through the IGFs (for review, see Spencer, 1983; Herington et al., 1983) .
Previous studies from our laboratory (Hascall et al., 1983; McQuillan et al., 1984 McQuillan et al., , 1986a have suggested that the stimulation of proteoglycan synthesis by serum is a co-ordinated process in the chondrocyte and is manifested at the level of DNA-dependent RNA synthesis. If, as suggested by this work, IGFs in foetal calf serum are responsible for this activity then this would suggest a potential mechanism of action of these growth factors. However, this is in contrast to other workers (Kemp et al., 1984) who have postulated a direct action of somatomedins at the level of RNA-dependent protein synthesis. Although IGF-I had a marked effect on proteoglycan synthesis by articular cartilage, this growth factor did not appear to affect the rate of loss of proteoglycans from the matrix. The absence of an effect of IGF-I on proteoglycan catabolism contrasts with the IGF-induced inhibition of protein degradation in a variety of other cell types (Ballard et al., 1980) . This suggests that the mechanism involved in the regulation of proteoglycan catabolism is independent of proteoglycan synthesis. Previous work from our laboratory (Campbell et al., 1984) indicated that the presence of foetal calf serum in the culture medium results in a suppression of proteoglycan catabolism compared with cultures maintained in medium alone, suggesting the presence of inhibitors or factors in serum capable of modulating the loss of proteoglycan from the matrix of cartilage.
The results presented in this study also show that the IGFs may be used to provide a defined medium for the study ofcartilage metabolism in vitro. By replacing foetal calf serum in the culture medium with IGF-I, adult articular cartilage can be maintained in a culture system where the phenotype and composition ofthe extracellular matrix of the tissue is conserved as observed in vivo. Furthermore, this work suggests that IGFs may have the potential to enhance the repair of the extracellular matrix of articular cartilage after damage, as seen in arthritis and degenerative joint disease.
